Literature DB >> 11319581

Paracetamol efficacy and safety in children: the first 40 years.

N Cranswick1, D Coghlan.   

Abstract

Paracetamol (acetaminophen) has a unique role in children because it is the first-line choice for the treatment of both fever and pain. When used in the recommended doses, it has few side effects and is remarkably well tolerated. While fever alone requires no treatment, when associated with discomfort or pain, paracetamol offers relief. Also, for mild to moderate pain, paracetamol, either alone or in combination with another drug, is effective. Even in severe pain, paracetamol offers a significant additive analgesic effect to opiates. Globally, the pediatric dose varies between 10 and 15 mg/kg. In the United Kingdom, 10 mg/kg is given every 4 hours, up to a maximum of four doses per day; in Australia, 15 mg/kg is administered 4-hourly up to a total dose of 60 mg/kg/day. In overdose, paracetamol is hepatotoxic. Single ingestions of more than ten times the recommended dose are potentially toxic. The development of specific antidotes and the universal availability of the Rumack-Matthew Nomogram have made the early treatment of overdose effective without long-term sequelae. There are sporadic case reports of chronic overdosing resulting in liver failure. Although the specific predictors are still being defined, exposures greater than 140 mg/kg/day for several days carry a risk of serious toxicity. In children, aspirin use has almost disappeared with the concurrent decline in Reye Syndrome. Less clinical experience has accumulated with ibuprofen, and it remains the second-line treatment for fever and pain. In conclusion, paracetamol remains the first-choice over-the-counter treatment for analgesia and antipyresis in children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11319581     DOI: 10.1097/00045391-200007020-00010

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  13 in total

Review 1.  Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity.

Authors:  Carolina I Ghanem; María J Pérez; José E Manautou; Aldo D Mottino
Journal:  Pharmacol Res       Date:  2016-02-26       Impact factor: 7.658

2.  Comparison of the Efficacy and Safety of 2 Acetaminophen Dosing Regimens in Febrile Infants and Children: A Report on 3 Legacy Studies.

Authors:  Anthony R Temple; Brenda Zimmerman; Cathy Gelotte; Edwin K Kuffner
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jan-Feb

3.  Fulminant hepatic failure and paracetamol overuse with therapeutic intent in febrile children.

Authors:  S Sri Ranganathan; M G Sathiadas; S Sumanasena; M Fernandopulle; S P Lamabadusuriya; B M R Fernandopulle
Journal:  Indian J Pediatr       Date:  2006-10       Impact factor: 1.967

Review 4.  Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs.

Authors:  Carolin Thomas; Lia Wurzer; Ernst Malle; Michael Ristow; Corina T Madreiter-Sokolowski
Journal:  Front Aging       Date:  2022-06-14

5.  Paracetamol induced hepatotoxicity.

Authors:  S B K Mahadevan; P J McKiernan; P Davies; D A Kelly
Journal:  Arch Dis Child       Date:  2006-03-17       Impact factor: 3.791

6.  Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain Management.

Authors:  Maurizio de Martino; Alberto Chiarugi
Journal:  Pain Ther       Date:  2015-10-30

Review 7.  The role of oxidative stress, inflammation and acetaminophen exposure from birth to early childhood in the induction of autism.

Authors:  William Parker; Chi Dang Hornik; Staci Bilbo; Zoie E Holzknecht; Lauren Gentry; Rasika Rao; Shu S Lin; Martha R Herbert; Cynthia D Nevison
Journal:  J Int Med Res       Date:  2017-03-16       Impact factor: 1.671

8.  Faster recovery and reduced paracetamol use - a meta-analysis of EPs 7630 in children with acute respiratory tract infections.

Authors:  Georg Seifert; Juliette Brandes-Schramm; Andrea Zimmermann; Walter Lehmacher; Wolfgang Kamin
Journal:  BMC Pediatr       Date:  2019-04-23       Impact factor: 2.125

9.  Approaches toward repeated supratherapeutic doses of paracetamol in children: a survey of medical directors of poison centres in North America and Europe.

Authors:  Eran Kozer; Michael McGuigan
Journal:  Drug Saf       Date:  2002       Impact factor: 5.228

10.  Availability, affordability and costs of pediatric medicines in Mongolia.

Authors:  Gereltuya Dorj; Bruce Sunderland; Tsetsegmaa Sanjjav; Gantuya Dorj; Byambatsogt Gendenragchaa
Journal:  BMC Pediatr       Date:  2018-05-02       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.